Company Monitoring Page for Idorsia

latest headlines for company on cafepharma

Second PhIII study for Idorsia's sleep drug returns positive results, but also raises new questions
Endpoints
Tue, 07/7/20 - 10:35 am
Tags:
Idorsia, daridorexant, insomnia, clinical trials
Idorsia's rival to Merck's insomnia drug clears phase 3 test
Fierce Biotech
Mon, 04/20/20 - 10:47 am
Tags:
Idorsia, Merck, insomnia, clinical trials, JNJ, daridorexant, Belsorma
Neurocrine signs $400M-plus deal with Idorsia for epilepsy drug
Pharmaforum
Fri, 01/10/20 - 10:23 am
Tags:
Idorsia, Neurocrine Biosciences, epilepsy, pediatric epilepsy, ACT-709478
Idorsia confirms 2019 spending plan as clinical trials "on track"
Yahoo/Reuters
Thu, 04/18/19 - 09:44 am
Tags:
Idorsia, clinical trials
Idorsia's selatogrel hits goals in phase 2 cardiovascular trials
Fierce Biotech
Tue, 12/18/18 - 10:37 am
Tags:
Idorsia, selatogrel, clinical trials, coronary artery disease, acute myocardial infarctions
J&J adds PhIII hypertension drug to the pipeline with $230M-plus cash deal for Idorsia
Endpoints
Mon, 12/4/17 - 11:43 am
Tags:
JNJ, hypertension, Idorsia, Actelion
The extraordinary adventure of Idorsia, the research-focused biotech, continues: first results two months after creation
GoInPharma
Sun, 08/27/17 - 06:23 pm
Tags:
Idorsia
Idorsia touts new sleep drug data ahead of PhIII; Tetraphase out to raise $65M
Endpoints
Fri, 07/28/17 - 10:38 pm
Tags:
Idorsia, ACT-541468, insomnia, Tetraphase

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.